Last reviewed · How we verify
Neodrol (androstanolone)
Neodrol (generic name: androstanolone) is a androstanolone drug. It is currently in unknown development for Anemia of chronic renal failure, Catabolic Process.
Neodrol works by binding to androgen receptors, mimicking the effects of natural androgens like testosterone.
Neodrol, also known as androstanolone, is a synthetic androgen steroid developed for the treatment of anemia of chronic renal failure and catabolic processes. It works by targeting sex hormone-binding globulin, a protein that binds to androgens, thereby increasing their availability in the body. As a small molecule androstanolone, Neodrol is not FDA-approved for any indications, but it has been used off-label for its anabolic and androgenic effects. The commercial status of Neodrol is unclear, but it is likely to be off-patent. Key safety considerations include potential virilizing effects and interactions with other medications.
At a glance
| Generic name | androstanolone |
|---|---|
| Drug class | androstanolone |
| Target | Sex hormone-binding globulin |
| Therapeutic area | Hematology |
| Phase | unknown |
Mechanism of action
Think of it like a key fitting into a lock. Neodrol is a small molecule that fits into androgen receptors, which are like locks on cells. When it binds, it triggers a response that helps build muscle and increase energy, similar to how testosterone works in the body.
Approved indications
- Anemia of chronic renal failure
- Catabolic Process
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Neodrol CI brief — competitive landscape report
- Neodrol updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Neodrol
What is Neodrol?
How does Neodrol work?
What is Neodrol used for?
What is the generic name of Neodrol?
What drug class is Neodrol in?
What development phase is Neodrol in?
What does Neodrol target?
Related
- Drug class: All androstanolone drugs
- Target: All drugs targeting Sex hormone-binding globulin
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Hematology
- Indication: Drugs for Anemia of chronic renal failure
- Indication: Drugs for Catabolic Process
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing